There was no significant difference in graft survival between the subgroups of Group A, though the augmented bladder group showed a trend toward poorer graft survival [mean estimated graft survival in augmented bladders was 81 months, 95% CI: 56–106 months vs. other abnormal LUT subgroups, for whom it was 116 months, 95% CI: 105–127, P = 0.09, Appendix Figures 2 and 3 .
← all excerpts
Renal transplantation into optimized abnormal lower urinary tract - Impact on graft outcomes, patient survival, and complications.
1
—
—